Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 58 for “"Bacille"”.
-
On the mechanism of action of intravesical Bacille Calmette-Guérin (BCG)
Intravesical Bacillus Calmette-Gu´erin (BCG) has been the standard treatment for high-risk NMIBC for over 40 years, yet up to half of patients experience recurrence or progression. The immune mechanisms underlying effective responses remain poorly defined. In this thesis, I investigated BCG’s …
-
Effects of exposure to environmental mycobacteria on immunity conferred by bacille calmette-guerin (BCG) vaccine
… that the efficacy of Mycobacterium bovis bacille Calmette- Gu??rin (BCG) as a tuberculosis vaccine may be influenced by prior host sensitisation to environmental mycobacteria (Env). This project evaluated the immune mechanisms underlying this phenomenon using a murine model of …
-
Evaluation of the non-specific effects of Bacille Calmette-Guérin (BCG) vaccination in healthy UK adults
<p>Tuberculosis is the leading single infectious disease killer in the world, and the global burden of LTBI and TB disease, with the addition of antimicrobial drug resistance means there is a desperate need for a safe and effective TB vaccine. BCG is the only licensed vaccine and extremely variable …
-
Vaccination of white-tailed deer with Mycobacterium bovis bacille Calmette-Guerin: efficacy, immunology, and molecular detection
… of oral and parenteral Mycobacterium bovis bacille Calmette-Guerin Danish strain 1331 (BCG) was evaluated for its ability to protect white-tailed deer against disease caused by M. bovis infection. In addition, cellular and humoral immune responses in deer to BCG vaccination and M. bovis …
-
Benefits and risks of neonatal bacille Calmette-Guerin (BCG) vaccination among Aboriginal infants in Canada: Assessment by Markov model
Bacille Calmette-Guerin (BCG) vaccine is given to Canadian Aboriginal neonates in communities at high risk for tuberculosis (TB). However, severe reactions and deaths associated with the vaccine have been reported among infants born with immunodeficiency syndromes. A Markov model was developed to …
-
Search for Surrogate Marker(s) of Immunity Following Vaccination with Experimental Vaccine (Autoclaved Leishmania Major + Bacille Calmette-Guérin) in Human Volunteers
Cutaneous leishmaniasis (CL) is usually a self-limiting lesion on the skin while visceral leishmaniasis is a progressive, systemic disease with high mortality even if treated. The problem associated with treatment and vector control justifies a search for an effective vaccine which seems to be the …
-
Using aerosol Bacille Calmette-Guérin in non-human primates to model the immune response to Mycobacterium Tuberculosis: a translational bridge between preclinical models and clinical trials
… aerosol to 1x107 colony forming units (CFU) of Bacille Calmette-Guérin (aeBCG). BCG is a live attenuated strain of Mycobacterium bovis, which can be used as a model of M.tb infection, and was safe to deliver to NHPs in a controlled manner.</p> <p>The immune response to aeBCG was characterised …
-
Immunomodulatory effects of mycobacteria
… responding to Env, against autologous M. bovis bacille Calmette-Gu??rin (BCG)-infected macrophages, was evaluated in peripheral blood cells of healthy adults and splenocytes of Env-immunised mice. T cell subsets and cytokines involved were also examined. The human study showed that Env-specific …
-
COMBINATORIAL ADMINISTRATION OF SYNTHETIC TLR4 AGONIST INI-2002 AND NOVEL MINCLE AGONIST UM-1098 DELIVERED VIA A-SNPS RESULTS IN SYNERGISTIC IL-1β PRODUCTION IN HUMAN PRIMARY CELLS AND ENHANCES TH1 AND TH17 RESPONSES IN VIVO
… with recent exception of SARS-CoV-2. Though the Bacille Calmette Guerin (BCG) vaccine confers protection against severe extrapulmonary forms of TB, there is no licensed vaccine for the prevention of pulmonary tuberculosis. The strongest correlate of protection against pulmonary tuberculosis is …
-
COMBINATORIAL ADMINISTRATION OF SYNTHETIC TLR4 AGONIST INI-2002 AND NOVEL MINCLE AGONIST UM-1098 DELIVERED VIA A-SNPS RESULTS IN SYNERGISTIC IL-1β PRODUCTION IN HUMAN PRIMARY CELLS AND ENHANCES TH1 AND TH17 RESPONSES IN VIVO
… with recent exception of SARS-CoV-2. Though the Bacille Calmette Guerin (BCG) vaccine confers protection against severe extrapulmonary forms of TB, there is no licensed vaccine for the prevention of pulmonary tuberculosis. The strongest correlate of protection against pulmonary tuberculosis is …
-
T cell independent mechanisms for protection against Mycobacterium tuberculosis infection
The live attenuated Mycobacterium bovis strain Bacille Calmette Guérin (BCG) is a potent innate immune stimulator. Innate Immunity provides the host with the ability to immediately respond to invasion by pathogens and can be utilized through the use of molecular adjuvants to trigger specific innate …
-
Evaluating the efficacy of a Mycobacterium bovis vaccine in feral swine
… bTB in wildlife and domestic livestock. Bacille Calmette-Guerin (BCG), a live, attenuated M. bovis strain vaccine used for tuberculosis prevention in humans has been variably effective in reducing bTB development in studies on various species. We hypothesize that Texas-origin feral swine …
-
The Effect of Leucogenenol on Classical Chemotherapy and Immunotherapy of Friend Virus Disease
… of the immunostiumulants leucogenenol and Bacille Calmette-Guerin (BCG) in combination with Methotrexate chemotherapy on Friend Virus Disease. Procedure. FV infected mice were treated with various combinations of the chemo-and immunotherapeutic agents being investigated. Three parameters of …
-
Innate immune responses to tuberculosis vaccines
… pulmonary tuberculosis varies between 0 and 80%. Bacille Calmette Guerin (BCG) has been administered to billions worldwide yet its protective mechanisms remain unknown, as do the reasons for its failure to protect in many parts of the world. Modified Vaccinia virus Ankara expressing antigen 85A …
-
Visible Light Controlled Combination Strategy to Treat Non-Muscle Invasive Bladder Cancer
… tumor and subsequent instillation of BCG (Bacille Calmette-Guérin) or chemotherapy are standard treatments for NMIBC. In BC, both chemotherapy and BCG are associated with significant side effects, including bladder contraction, bleeding, and recurrences within the first five years. Because …
-
Characterizing the role of the HspX protein from Mycobacterium tuberculosis as a subunit vaccine candidate in the small animal model of tuberculosis
… of the closely related Mycobacterium bovis Bacille-Calmette Guerin (BCG), which offers little protection against pulmonary disease in adults, particularly against latent infection. Current vaccine strategies against TB include the development of subunit vaccines, which contain one to a few …
-
Investigating the role of memory alveolar macrophages in early innate immune control of pulmonary tuberculosis
… all despite the near universal implementation of bacille Calmette-Guérin (BCG) vaccination across TB endemic areas. BCG is capable of preventing childhood disseminated forms of disease but fails to induce potent immunity within the lung. We expect this to in part play a role in the lack of …
-
Cell-Type Specific Immune Profiles Inform Tuberculosis Disease Severity and Protective Efficacy Outcomes of an Attenuated Mycobacterium tuberculosis Vaccine Candidate
… preventive strategy, vaccination of infants with Bacille Calmette-Guérin (BCG), a live attenuated strain of Mycobacterium bovis, is widely used around the world. However, BCG only provides immunity until ~15 years of age and has severe limitations in adult populations. Over the past 10 years there …
-
Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
<p>The efficacy of Bacille-Calmette Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). Given the variable efficacy of BCG an …
Page 1 of 3